KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short term Debt (2016 - 2025)

Historic Short term Debt for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $4.5 billion.

  • Bristol Myers Squibb's Short term Debt rose 31827.46% to $4.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 billion, marking a year-over-year increase of 31827.46%. This contributed to the annual value of $2.0 billion for FY2024, which is 3440.21% down from last year.
  • Bristol Myers Squibb's Short term Debt amounted to $4.5 billion in Q3 2025, which was up 31827.46% from $4.7 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Short term Debt high stood at $7.5 billion for Q1 2022, and its period low was $1.1 billion during Q3 2024.
  • Moreover, its 5-year median value for Short term Debt was $3.6 billion (2025), whereas its average is $3.9 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Short term Debt soared by 32329.77% in 2022 and then plummeted by 8028.17% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Short term Debt stood at $4.9 billion in 2021, then fell by 13.82% to $4.3 billion in 2022, then fell by 26.85% to $3.1 billion in 2023, then plummeted by 34.4% to $2.0 billion in 2024, then soared by 120.38% to $4.5 billion in 2025.
  • Its Short term Debt was $4.5 billion in Q3 2025, compared to $4.7 billion in Q2 2025 and $3.6 billion in Q1 2025.